# Amber Therapeutics Holdings (Amber Therapeutics Holdings Limited) Private limited company registered in Didcot, classed under “Research and experimental development on biotechnology”. - Company number: 13089338 - Status: Active - Type: Private limited company - Incorporated: 18 December 2020 - Registered office: Unit 1 Tech Foundry 2, Curie Avenue, Didcot, OX11 0QQ - Location: Didcot - Activity: Research and experimental development on biotechnology ## Latest filed profit Profit after tax in the year to 31 December 2025: **loss of £28.3m**, from its latest filed accounts. Turnover, net assets, cash, staff, earlier years, ratios and owners are on the page for subscribers. ## Questions people ask ### What does Amber Therapeutics Holdings do? Private limited company registered in Didcot, classed under “Research and experimental development on biotechnology”. ### How much turnover does Amber Therapeutics Holdings make? Answered on the page for FirmFacts Pro subscribers: https://firmfacts.co/company/amber-therapeutics-holdings-13089338 ### Is Amber Therapeutics Holdings profitable? No: it made a loss after tax of £28.3m in the year to 31 December 2025, its latest filed accounts. ### How many people work at Amber Therapeutics Holdings? Answered on the page for FirmFacts Pro subscribers: https://firmfacts.co/company/amber-therapeutics-holdings-13089338 ### Who runs and owns Amber Therapeutics Holdings? Its directors are David Rogers Amerson, Caroline Butler, Liliane Doctor Chamas, Yen-Min Kevin Chu, Aidan Harold Winston Crawley and 1 more. Its owners are shown to subscribers. ### Where is Amber Therapeutics Holdings based? Its registered office is Unit 1 Tech Foundry 2, Curie Avenue, Didcot, OX11 0QQ, in Didcot. ### When was Amber Therapeutics Holdings founded? Amber Therapeutics Holdings Limited was incorporated on 18 December 2020. ### Is Amber Therapeutics Holdings still trading? The register lists Amber Therapeutics Holdings Limited as active. ## Timeline Recent filings and changes at Companies House. - 2026-10-15: Statement of capital following an allotment of shares on 15 October 2026 · GBP 15,947.226 (and 15 more like it since 4 May 2021) - 2026-09-21: Group of companies' accounts made up to 31 December 2025 - 2026-07-22: Memorandum and Articles of Association (and 2 more like it since 12 July 2021) - 2026-07-22: Resolutions (and 6 more like it since 30 April 2021) - 2025-12-23: Notification of Oxford Science Enterprises Holdings Ii Limited as a person with significant control on 28 May 2025 - 2025-12-23: Cessation of Oxford Science Enterprises Plc as a person with significant control on 28 May 2025 - 2025-12-18: Replacement Filing for the appointment of Mr David Rogers Amerson as a director - 2025-09-05: Group of companies' accounts made up to 31 December 2024 - 2025-06-17: Registered office address changed from Cannon Place 78 Cannon Street London EC4N 6AF England to Unit 1 Tech Foundry 2 Curie Avenue Didcot OX11 0QQ on 17 June 2025 - 2025-06-16: Second filing of a statement of capital following an allotment of shares on 15 April 2025 · GBP 8,629.505 (and 3 more like it since 30 June 2021) - 2025-04-15: Appointment of Mr Dave Amerson as a director on 15 April 2025 - 2024-09-18: Group of companies' accounts made up to 31 December 2023 - 2024-07-11: Certificate of change of name - 2024-07-11: Change of name notice - 2024-05-31: Notification of Oxford Science Enterprises Plc as a person with significant control on 23 May 2024 - 2024-05-31: Withdrawal of a person with significant control statement on 31 May 2024 - 2024-05-24: Termination of appointment of Tim Denison as a director on 23 May 2024 - 2024-05-24: Termination of appointment of Jonathan Martin Glenn as a director on 30 April 2024 - 2024-05-24: Appointment of Tiffany Le as a director on 23 May 2024 - 2024-05-24: Appointment of Caroline Butler as a director on 23 May 2024 - 2024-05-24: Appointment of Yen-Min Kevin Chu as a director on 23 May 2024 - 2024-04-16: Director's details changed for Aidan Harold Winston Crawley on 1 October 2021 - 2024-01-26: Appointment of Mr Jonathan Martin Glenn as a director on 1 December 2023 - 2023-08-21: Particulars of variation of rights attached to shares - 2023-08-21: Change of share class name or designation --- Source: Companies House filings (Open Government Licence v3.0). Figures are as filed; nothing is estimated. Page: https://firmfacts.co/company/amber-therapeutics-holdings-13089338